Edwards Lifesciences Corporation (EW) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Edwards Lifesciences Corporation (EW) - Medical Equipment - Deals and Alliances Profile

Edwards Lifesciences Corporation (EW) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Edwards Lifesciences Corporation (EW) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
73 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Edwards Lifesciences Corporation (Edwards) operates in the heart valves and hemodynamic monitoring industry. The company develops, manufactures and markets products and technologies used for the treatment of structural heart disease and critically illness. It develops and commercializes heart valve products such as tissue heart valves and repair products, which are used for the replacement of repairing of a patient's diseased or defective heart valve. Edwards also offers hemodynamic monitoring systems, which is used for the measurement of a patient's cardiovascular function in the hospital setting. The company operates across the US, Europe, Japan and rest of world.

Edwards Lifesciences Corporation (EW) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  
Source:
Document ID
GDME692D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Edwards Lifesciences Corporation, Medical Equipment, Deals By Year, 2010 to YTD 201652
Edwards Lifesciences Corporation, Medical Equipment Deals By Type, 2010 to YTD 201671
Edwards Lifesciences Corporation, Medical Equipment, Deals By Region, 2010 to YTD 201681
Edwards Lifesciences Corporation, Medical Equipment, Deals By Market, 2010 to YTD 201691
Edwards Lifesciences Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016102
Edwards Lifesciences Corporation, Medical Equipment, Deal Details1225
  Venture Financing121
    V-Wave Raises USD28 Million in Venture Financing122
    CardioKinetix Raises USD50 Million in Venture Financing142
    Middle Peak Medical Raises US$11.5 Million In Series A Venture Financing162
    Cardiaq Valve Technologies Raises US$37.3 Million In Series B Financing182
    Cardiaq Valve Technologies Raises US$32.5 Million In Venture Financing201
    CardiAQ Valve Technologies Secures US$6.5 Million In Series A Financing Round211
  Partnerships221
    EndoEvolution Enters Into Licensing Agreement With Edwards Lifesciences For Endo360221
    Edwards Lifesciences Enters Into Licensing Agreement With Harbor MedTech231
    Edwards Lifesciences Enters Into Licensing Agreement With Philips241
    Edwards Lifesciences Enters into Agreement with CareFusion251
    CollPlant Enters Into An Agreement With Edwards Lifesciences261
  Equity Offering271
    Harpoon Medical Raises Funds through Private Placement271
  Debt Offering281
    Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million282
  Acquisition301
    Edwards Lifesciences Invests in Harpoon Medical301
    Edwards Lifesciences Acquires CardiAQ for up to USD400 Million311
    Edwards Lifesciences Receives an Option to Acquire CardioKinetix321
    Edwards Lifesciences Acquires Bmeye, Cardiovascular Monitoring Company, For US$42 Million332
    Edwards Lifesciences Completes Acquisition Of Embrella Cardiovascular352
Edwards Lifesciences Corporation - Key Competitors371
Key Employees382
Locations And Subsidiaries403
  Head Office401
  Other Locations &Subsidiaries403
Recent Developments431
Strategy And Business Planning431
Dec 09, 2015: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference432
Financial Announcements451
Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results452
Feb 02, 2016: Edwards Lifesciences Reports Fourth Quarter Results472
Oct 26, 2015: Edwards Lifesciences Reports Third Quarter Results-2015492
Jul 28, 2015: Edwards Lifesciences Reports Second Quarter Results512
Apr 23, 2015: Edwards Lifesciences Reports First Quarter Results531
Feb 03, 2015: Edwards Lifesciences Reports Fourth Quarter And Full Year Results542
Corporate Communications561
Jul 05, 2016: Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors561
Mar 17, 2016: Steven Loranger Appointed To Edwards Lifesciences Board Of Directors571
Jul 30, 2015: Edwards Announces Board Change581
Feb 10, 2015: Edwards Announces Board Changes591
Product News601
Mar 16, 2016: Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan601
Mar 02, 2016: Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures611
Oct 15, 2015: Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-in-valve Procedures621
Mar 24, 2015: Edwards' CEO Addresses Senate Committee On Preserving And Strengthening Medical Device Innovation In The U.S.631
Mar 15, 2015: Five-Year Outcomes For High-Risk Sapien Patients Demonstrate Equivalence To Surgery, Durable Valve Performance641
Mar 15, 2015: SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients651
Product Approvals661
Mar 16, 2016: Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan661
Mar 02, 2016: Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures671
Oct 15, 2015: Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-in-valve Procedures681
Clinical Trials691
Mar 15, 2015: SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients691
Mar 15, 2015: Five-Year Outcomes For High-Risk Sapien Patients Demonstrate Equivalence To Surgery, Durable Valve Performance701
Other Significant Developments711
Oct 23, 2015: Martha Marsh Appointed To Edwards Lifesciences Board Of Directors711
Jun 03, 2015: Edwards Heart Valve Pioneer Starr Receives Prestigious Scientific Honor721
Appendix731
  Methodology731
  About GlobalData731
  Contact Us731
  Disclaimer731

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Edwards Lifesciences Corporation (EW) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Edwards-Lifesciences-Corporation-EW-Medical-Equipment-Deals-and-Alliances-Profile-2148-6409>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Edwards Lifesciences Corporation (EW) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Edwards-Lifesciences-Corporation-EW-Medical-Equipment-Deals-and-Alliances-Profile-2148-6409>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research